• Go to navigation
  • Go to content
Patient Health International

You are here

  • Home
  • CRESTOR™ (rosuvastatin)

Astrazeneca global websites

  • AstraZeneca Websites

Main navigation

  • Home
  • News & feature articles
  • Body map
  • List of health conditions
  • Lung cancer
  • Interactive area
  • Interactive learning
  • About medicines
  • AstraZeneca medicines
  • About clinical trials
  • Glossary
  • Links
  • Sitemap

CRESTOR™ (rosuvastatin)

Alternative brand (trade) names:

What is CRESTOR™ ?

CRESTOR contains the medicine rosuvastatin, which belongs to a group of medicines known as HMG-CoA reductase inhibitors, or ‘statins’.

What is CRESTOR™ used for?

CRESTOR is used to modify abnormal levels of fatty substances in the blood called lipids, mainly high levels of cholesterol and triglycerides. CRESTOR is used in combination with a diet plan when changes to diet and exercise alone have failed to lower high cholesterol and triglycerides.

How does CRESTOR™ work ?

Rosuvastatin belongs to a group of medicines known as HMG-CoA reductase inhibitors, or ‘statins’.

  • HMG-CoA reductase is an enzyme (chemical) in the body which converts 3-hydroxy-3-methylglutaryl coenzyme A to mevalonate, which is then converted to cholesterol.

  • By inhibiting HMG-CoA reductase, CRESTOR reduces the total amount of cholesterol produced by the body.

  • There are 2 types of cholesterol in the blood, LDL-cholesterol (“Bad Cholesterol”) and HDL-cholesterol (“Good cholesterol”)

  • By inhibiting HMG-CoA reductase, CRESTOR results in lower levels of (“Bad”) LDL-cholesterol and reduces triglycerides in the blood.

CRESTOR also leads to increased levels of (“Good”) HDL-cholesterol in the blood.

How is CRESTOR™ given ?

CRESTOR is available as a once a day tablet which may be given at any time of day and can be taken with or without food.

Country specific information

To consult your local information.

Any medical information on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. Read more important information.

Back to search

  • Advanced search

Quick links

  • Investor information
  • Press information
  • AstraZeneca US

Page tools

  • Print
  • Bookmark this page

Related links

  • Other countries

List of conditions

AstraZeneca medicines

AstraZeneca International

Legal notices

  • Legal notice
  • Privacy policy
  • © AstraZeneca 2009